SCHEMBL23958226

SCHEMBL23958226

O=c1c2ncccc2nc(Nc2cccnc2)n1-c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAD52 P43351 1/20 0.45
KMT2A Q03164 1/20 0.45
ALOX12 P18054 1/20 0.43
CYP17A1 P05093 1/20 0.41
PIK3CD O00329 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
USP2 O75604 1/20 0.40
PDE5A O76074 2/20 0.40
PDE7A Q13946 1/20 0.40
CDK4 P11802 1/20 0.39
CCND1 P24385 1/20 0.39
CCND2 P30279 1/20 0.39
CCND3 P30281 1/20 0.39
MDM2 Q00987 1/20 0.39
LCK P06239 1/20 0.39
KDR P35968 1/20 0.38
LOXL3 P58215 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24110995 0.86 ALOX12 (0.57) RAD52KMT2AALOX12RAB9AUSP2
SCHEMBL23958218 0.85 ALOX12 (0.43) RAD52KMT2AALOX12PDE7AMDM2
SCHEMBL24110973 0.83 ALOX12 (0.47) RAD52KMT2AALOX12RAB9AUSP2
SCHEMBL23958331 0.82 LOXL3 (0.47) RAD52KMT2AALOX12RAB9APDE5A
SCHEMBL24111000 0.82 ALOX12 (0.49) RAD52KMT2AALOX12RAB9AUSP2
SCHEMBL23958355 0.81 ALOX12 (0.46) RAD52KMT2AALOX12PIK3CDMDM2
SCHEMBL24110960 0.81 PIK3CD (0.44) RAD52KMT2AALOX12PIK3CDUSP2
SCHEMBL24110981 0.78 ALOX12 (0.43) RAD52KMT2AALOX12USP2PDE5A
SCHEMBL23958121 0.78 ALOX12 (0.43) RAD52KMT2AALOX12USP2PDE5A
SCHEMBL23958265 0.78 PIK3CD (0.46) RAD52KMT2AALOX12PIK3CDPDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2021-12-16 US disclosed
WO-2021215537-A1 2-HETEROARYLAMINOQUINAZOLINONE DERIVATIVE 大日本住友製薬株式会社 (JP) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE CRKL, CLIC4, CLIC1 RAD52 1428/4885KMT2A 1451/4885ALOX12 3240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.